Prediction of preterm birth: past, present, and future approaches to an ongoing challenge

Christine Henricks1, David Nelson1

  • 1Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390-9032, USA; Parkland Health 5200 Harry Hines Blvd, Dallas, TX 75235, USA.

Seminars in Perinatology
|December 6, 2025
PubMed

Insights

Predicting preterm birth remains challenging, as traditional methods lack accuracy. Emerging technologies like AI and multi-omics show promise for improving prediction, but require validation across diverse populations.

Area of Science:

  • Perinatal health
  • Reproductive medicine
  • Genomics and proteomics

Background:

  • Preterm birth is a leading cause of neonatal morbidity and mortality globally, with rates largely unchanged despite extensive research.
  • Conventional prediction methods (risk scoring, cervical length, fetal fibronectin) offer limited accuracy.
  • There is an urgent need for advanced predictive and preventative strategies for preterm birth.

Purpose of the Study:

  • To review emerging technologies for preterm birth prediction.
  • To highlight the potential of multi-omics and artificial intelligence in improving predictive accuracy.
  • To discuss challenges and future directions for clinical translation.

Main Methods:

  • Review of proteomic, metabolomic, and genetic studies.
  • Application of artificial intelligence (AI) and machine learning (ML) to integrate multi-omics and clinical data.
  • Analysis of limitations including heterogeneous definitions, small sample sizes, and lack of diverse validation.

Main Results:

  • Proteomics identified inflammation and angiogenesis pathways; metabolomics revealed biochemical and microbial alterations.
  • Genetic studies indicated complex maternal and fetal genomic contributions.
  • Early AI/ML studies suggest improved predictive accuracy over conventional models, but challenges persist.

Conclusions:

  • Emerging technologies, particularly AI integrating multi-omics data, offer new avenues for preterm birth prediction.
  • Significant challenges remain, including study heterogeneity, validation across diverse populations, and addressing social determinants of health.
  • Continued innovation, longitudinal research, and a focus on equity are crucial for clinical translation and improving perinatal outcomes.

Related Concept Videos

Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.8K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K